October 20, 2014
UC San Diego Sanford Stem Cell Clinical Center is pushing therapeutic stem cell-based science out of the laboratory and closer to real-world medical applications. The unprecedented trials involve potential therapies for spinal cord injuries, Type 1 diabetes and chronic lymphocytic leukemia.
May 22, 2017
Liver cirrhosis is the 12th leading cause of mortality worldwide and approximately half of those deaths are due to alcohol abuse. Yet apart from alcohol abstinence, there are no specific treatments to reduce the severity of alcohol-associated liver disease. Researchers at University of California San Diego School of Medicine and…
March 14, 2024
Hungarian-American biochemist and researcher Katalin Karikó has been selected by Scripps Institution of Oceanography at UC San Diego as the recipient of the 2023 Nierenberg Prize for Science in the Public Interest.
October 30, 2014
…safety of a monoclonal antibody treatment that targets cancer stem cells in patients with chronic lymphocytic leukemia, the most common form of blood cancer. “What we are seeing after years of work is the rubber hitting the road,” said Lawrence Goldstein, director of the UC San Diego Stem Cell Program…
December 10, 2020
…type of immunotherapy, an antibody, and he did fairly well at the beginning,” said Cohen. “But, again his cancer began to grow and, unfortunately, progressed.” While the COVID-19 pandemic continues to sicken people worldwide, UC San Diego Health has resumed previously paused medical services. This allowed Cohen, and colleagues Dr.…
September 3, 2020
…clinical test that uses antibody probes to detect S. aureus bacteremia-associated proteins. They are also expanding the approach to look at proteomic and metabolomic markers indicative of high-risk patients with other types of infections, including COVID-19. In addition, researchers are following up on the proteins and modifications that were revealed…
September 6, 2022
Noted businessman and philanthropist T. Denny Sanford has committed $150 million in new funding to expand and, in some ways, quite literally launch stem cell research and regenerative medicine at University of California San Diego into new spaces and endeavors.
March 6, 2018
The study, published in the March 5 online edition of the Proceedings of the National Academy of Sciences (PNAS), describes how the supercomputing power of Gordon, Comet, and GPU clusters, all based at the San Diego Supercomputer Center at UC San Diego, were used with improved accelerated molecular dynamics (aMD)…
August 20, 2020
…test does not measure antibodies or detect whether or not you have had the virus in the past. All employee testing is voluntary. Why sign up to take your test if you have no symptoms? “Over the last few months, numerous studies have pointed to the absence of symptoms in…
November 24, 2021
Artificial intelligence-based technique reveals previously unknown cell components that may provide new clues to human development and disease.
